Wall Street is going gaga about the prospect of Medicinal Mushrooms!!!
Psilocybin, also known as a magic mushroom or a psychedelic mushroom, is said to be the key to treating depression and many other mental issues such as anxiety, addiction, and even Alzheimer’s Disease.
Imagine you had shares of the FIRST Cannabis Stock when it first hit the markets – Canopy Growth, You’d have turned $1000 into over $20,000!
Last May, residents of Denver, Colorado voted to Decriminalize the drug, and Oakland, California’s city council unanimously concluded that consuming numerous psychedelic plants, mushrooms included, should not be considered criminal. This year Santa Cruz become the latest city to decriminalize “magic mushrooms” and other natural psychedelics, including ayahuasca and peyote.
Like Cannabis, the movement to decriminalize magic mushrooms is picking up steam across the U.S. So this could just be getting started!
Minerco Inc (OTC: MINE) recently announced that it expects to be the first Company in the Magic Mushroom industry to open an entire facility dedicated towards the distribution of its micro dosing product lines in addition to the CBD and Delta 8 products, amongst others, that will also be distributed by WLLCO, a white label CBD company that the Company acquired last month.
The Company initially announced on March 29, 2021 it had finalized a lease that will enable them to clearly solidify its position as the first mover in the nation’s rapidly emerging and highly lucrative Magic Mushroom industry.
Ann Arbor, Michigan Decriminalizes Psychedelics, Including Magic Mushrooms
The city of Ann Arbor, Michigan was one of the first cities across the nation that recently decriminalized psychedelic plants, paving the way for innovative companies like Minerco to quickly build a brand name for its product lines as it prepares for a nationwide rollout strategy, in conjunction with the decriminalization of additional cities across the nation,” said Julius Jenge, Chairman and CEO of Minerco, Inc. “Ann Arbor’s resolution defines entheogenic plants as plants and fungi that contain indole amines, tryptamines and phenethylamines ‘that can benefit psychological and physical wellness, support and enhance religious and spiritual practices, and can reestablish human’s inalienable and direct relationship to nature.’ We are firm believers in the healing powers that psychedelic plants can have on patients that are continuing to suffer from traditional Western medicine and are eagerly looking forward to introducing Minerco’s treatment for a wide variety of ailments, from depression to insomnia,” concluded Mr. Jenge.
Although investors may be discouraged by the stock’s recent fall, it’s important to remember this is a good long-term hold. Minerco Inc (OTC: MINE) has a strong business model, and with the company focusing on its CBD & psilocybin portfolio, we could see a lot more growth in the years to come.